National Health Investors, Inc.

National Health Investors is rated 'Hold' as portfolio shifts and recent asset sales pressure near-term earnings and dividend growth. NHI's SHOP segment expansion is a key strategic focus, but same-store NOI declined, raising concerns about execution as SHOP grows to 40–50% of the portfolio. Following the $560M NHC sale, NHI's balance sheet is robust with pro forma net debt/EBITDA at 2.5x and no significant maturities until 2028.

National Health Investors trades at a discount after a perceived unfavorable lease resolution and SHOP segment underperformance, creating an attractive entry point. NHI's $560M sale of skilled nursing assets to NHC is being redeployed into higher growth, newer SHOP properties. Market concerns about SHOP underperformance are overstated; recent acquisitions differ materially from legacy assets and are poised for stronger growth.

Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either DiamondRock Hospitality (DRH) or National Health Investors (NHI). But which of these two stocks is more attractive to value investors?

The oldest baby boomers turn 80 this year, and the gap between senior housing demand and new supply is growing faster than most investors realize.